Apple has filed a new inter partes review petition at the Patent Trial and Appeal Board, opening IPR2026-00437 on August 17, 2026. At this stage, the publicly available docket information is limited, but the filing itself is noteworthy for patent litigators and in-house IP teams tracking how major technology companies are using PTAB proceedings as part of broader enforcement and defense strategies.

The proceeding is captioned Apple Inc., indicating Apple is the petitioner seeking review of an issued patent.

Apple Inc. has launched a new challenge at the Patent Trial and Appeal Board, filing inter partes review petition IPR2026-00438 on August 17, 2026. At this early stage, the docket signals the opening of another high-stakes PTAB contest involving one of the most active technology companies in the patent arena. For practitioners tracking repeat PTAB filers, portfolio pressure campaigns, or parallel district court strategy, this is a proceeding worth watching.

The petitioner is Apple Inc.. Based on the currently available case information, Apple is seeking PTAB review of an issued patent, with the patent owner and the specific patent number expected to become clearer as the petition and related filings are further reflected on the docket.

A new post-grant review at the Patent Trial and Appeal Board could be one to watch for companies operating in the dental implant and broader medical-device space. On August 11, 2026, Straumann USA, LLC filed PGR2026-00070, asking the PTAB to review a recently issued patent.

A new petition at the Patent Trial and Appeal Board, IPR2026-00413, was filed on August 14, 2026, and names Luxottica of America Inc. in the proceeding caption. For patent practitioners tracking activity in the eyewear, retail, consumer products, or branded technology spaces, this is a matter worth watching as the record develops.

At this early stage, the publicly available docket information identifies the proceeding title, filing date, and PTAB docket number, but key details that practitioners will want—most notably the patent number being challenged, the full party alignment between petitioner and patent owner, and the specific invalidity grounds asserted under 35 U.S.C. §§ 102 and/or 103—will likely become clearer as the petition and accompanying papers are added to the docket.

That said, the filing itself is significant.

A new post-grant review petition has been filed at the Patent Trial and Appeal Board against Straumann USA, LLC, opening what could become a closely watched dispute for practitioners in the dental and medical-device patent space. The proceeding, PGR2026-00070, was filed on August 11, 2026. View full case on Docket Alarm

At this early stage, the PTAB docket identifies Straumann USA, LLC in the case caption, but practitioners will want to watch the filing record closely to confirm the specific patent number at issue, the named petitioner, and the precise claims challenged once the petition and related papers are available through the docket.

The Patent Trial and Appeal Board has issued its Final Written Decision in IPR2025-00070, bringing the inter partes review to its merits-stage conclusion and giving practitioners another look at how the Board is applying patentability standards in contested post-grant proceedings. View full case on Docket Alarm

Because a Final Written Decision is the PTAB’s definitive resolution of the challenged claims and grounds that were instituted, the opinion matters well beyond the immediate dispute.

A new post-grant review at the Patent Trial and Appeal Board could be worth close attention for companies operating in the dental implant and medical device space. In PGR2026-00070, filed on August 11, 2026, the proceeding is captioned Straumann USA, LLC, signaling a challenge to a recently issued patent associated with one of the best-known names in dental technology.

At this stage, the docket entry identifies the matter by party name and PTAB number, but practitioners will want to watch for the petition and related filings to clarify the specific patent claims at issue, the identity of the petitioner, and the precise invalidity theories being advanced.

Meta Platforms, Inc. has launched a new inter partes review at the Patent Trial and Appeal Board, filing IPR2026-00420 on August 7, 2026. The petition opens another closely watched PTAB contest involving a major technology company and underscores how frequently the Board remains central to high-stakes patent strategy.

At this early stage, the docket identifies the proceeding by petitioner name—Meta Platforms, Inc.—but the publicly available case caption information does not yet disclose the full patent details or the patent owner in the materials summarized here.

Meta Platforms, Inc. has launched a new inter partes review at the Patent Trial and Appeal Board in IPR2026-00426, filed on August 5, 2026.

Meta Platforms, Inc. has launched a new inter partes review proceeding at the Patent Trial and Appeal Board in IPR2026-00420, filed on August 7, 2026.

Luxottica of America Inc. has filed a new inter partes review proceeding at the Patent Trial and Appeal Board, opening another matter for practitioners tracking how major consumer-brand companies use PTAB challenges as part of broader patent defense strategy. The petition, docketed as IPR2026-00412 and filed on August 7, 2026, is now pending before the Board.

At this early stage, the PTAB docket entry identifies Luxottica of America Inc. in the case caption, but the publicly available case summary does not yet provide the full set of details practitioners will want to monitor closely, including the challenged patent number, the named patent owner, and the specific prior-art grounds asserted in the petition.

In a July 29, 2026 final written decision, the Patent Trial and Appeal Board held that the petitioner failed to prove any challenged claim unpatentable in IPR2025-00574. The judgment, issued under 35 U.S.C. § 318(a), is a complete defense win for the patent owner: none of the instituted challenges succeeded.

At a high level, that means the Board was not persuaded that the prior art and supporting expert testimony carried the petitioner’s burden by a preponderance of the evidence.

Google LLC has filed a new inter partes review petition at the Patent Trial and Appeal Board in IPR2026-00429, opening another closely watched front in the company’s broader patent defense strategy. The proceeding, filed on July 29, 2026, is captioned simply Google LLC, but as with any PTAB matter, the key questions for patent practitioners will be which patent claims are under attack, what prior art combinations are being asserted, and whether the Board views the petition as a strong candidate for institution.

At this early stage, the docket signals the beginning of the challenge rather than its resolution.

Google LLC has filed a new inter partes review petition at the Patent Trial and Appeal Board, opening IPR2026-00418 on July 30, 2026.

A new inter partes review, IPR2026-00408, was filed at the Patent Trial and Appeal Board on July 28, 2026, under the caption Zhuhai CosMX Battery Co., Ltd. For patent practitioners tracking battery-sector disputes and PTAB filing trends, this is a proceeding worth watching as the record develops.

At this early stage, the publicly available docket information identifies the petitioner as Zhuhai CosMX Battery Co., Ltd., but the initial case caption alone does not yet provide the full picture of the challenged patent, the patent owner, or the specific prior-art combinations being asserted.